Best Practice & Research Clinical Haematology
Latest Publications

TOTAL DOCUMENTS

1337

(FIVE YEARS 113)

H-INDEX

60

(FIVE YEARS 3)

Published By Elsevier

1521-6926

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Editorial Board / Aims & Scope

Best Practice & Research Clinical Haematology ◽

10.1016/s1521-6926(21)00105-5 ◽

2021 ◽

Vol 34 (4) ◽

pp. 101340

Download Full-text

Can Venetoclax-based Therapy Replace 7+3 Induction in Fit Older Adults with AML?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101335 ◽

2021 ◽

pp. 101335

Author(s):

James M. Foran

Keyword(s):

Older Adults

Download Full-text

Can Molecular Insights Guide Treatment of AML Evolved from MPNs?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101323 ◽

2021 ◽

pp. 101323

Author(s):

John Crispino ◽

Raajit RampalD

Download Full-text

How do molecular aberrations guide therapy in MDS?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101324 ◽

2021 ◽

pp. 101324

Author(s):

Rafael Bejar

Keyword(s):

Molecular Aberrations

Download Full-text

It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDS

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101325 ◽

2021 ◽

pp. 101325

Author(s):

Luis E. Aguirre ◽

Rami Komrokji ◽

Eric Padron

Keyword(s):

High Risk ◽

Myelodysplastic Syndromes ◽

Combinatorial Therapy ◽

Treatment Paradigm

Download Full-text

How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101327 ◽

2021 ◽

pp. 101327

Author(s):

David P. Steensma

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Clonal Hematopoiesis ◽

Acute Myeloid

Download Full-text

What is the Role of the Bone Marrow Microenvironment in AML?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101328 ◽

2021 ◽

pp. 101328

Author(s):

Nirupama Mulherkar ◽

David T. Scadden

Keyword(s):

Bone Marrow ◽

Bone Marrow Microenvironment

Download Full-text

Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndrome?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101332 ◽

2021 ◽

pp. 101332

Author(s):

Christian Niederwieser ◽

Nicolaus Kröger

Keyword(s):

Myelodysplastic Syndrome ◽

Current Status ◽

Intensive Chemotherapy ◽

Hypomethylating Agents

Download Full-text

Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101331 ◽

2021 ◽

pp. 101331

Author(s):

Thai Hoa Tran ◽

Sarah K. Tasian

Download Full-text

Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2021.101329 ◽

2021 ◽

pp. 101329

Author(s):

Lindsey E. Montefiori ◽

Charles G. Mullighan

Keyword(s):

Acute Leukemias ◽

Biological Basis

Download Full-text